Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
506,304
-
Share change
-
+97,550
-
Total reported value
-
$11,519,000
-
Price per share
-
$22.75
-
Number of holders
-
14
-
Value change
-
+$2,223,472
-
Number of buys
-
9
-
Number of sells
-
3
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q2 2020
As of 30 Jun 2020,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
506,304 shares.
The largest 10 holders included
Ibex Investors LLC, MORGAN JESS S & CO INC, RENAISSANCE TECHNOLOGIES LLC, HighTower Advisors, LLC, Virtu Financial LLC, BANK HAPOALIM BM, MORGAN STANLEY, ROYAL BANK OF CANADA, ADVISOR GROUP HOLDINGS, INC., and UBS Group AG.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.